Search
SOLACI Congress
HomeCONGRESSInternational Congresses

International Congresses

View Category
Day 2

OCT-STEMI: Primary angioplasty guided by OCT

This study included 201 patients suffering ST-segment elevation acute coronary syndrome and randomized to the use of...
solaci -
Learn More
Day 2

RIBS IV: Drug-eluting balloon versus everolimus-eluting stent on in-stent restenosis

This prospective, multicenter, randomized trial compared the paclitaxel-eluting balloon versus everolimus-eluting stent to treat patients with in-stent...
solaci -
Learn More
Day 2

ABSORB 2: Results at one year of bioabsorbable platform versus Xience

This randomized, controlled, multicenter and blind study compared the second generation of bio-absorbable stent platform with the...
solaci -
Learn More
Day 3

SOURCE XT: Results at 2 years of SAPIEN XT valve

Multicenter prospective study included 2688 patients with a mean age of 81.4 years and 20.5 EuroScore. The...
solaci -
Learn More
Day 3

NOBORI II: Final 5-year results of drug-eluting stent with bio-absorbable polymer

This study evaluated the performance of Nobori biolimus bio-absorbable polymer stent in real-world patients. A total of...
solaci -
Learn More
Day 3

TRYTON dedicated bifurcation stent in left main coronary artery

TRYTON is a cobalt chromium device specifically dedicated for bifurcation lesions to be implanted in the side...
solaci -
Learn More
Day 3

UK TAVI Registry: Long-term results of TAVI in the UK

This record has been created in order to evaluate the results of percutaneous aortic valve replacement in...
solaci -
Learn More
Day 3

DISCOVER Trial: Results at one year of the new nonmetallic percutaneous aortic valve

Direct Flow Medical prosthesis is a nonmetallic, repositionable, recaptured valve (even after posts dilate), that does not...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Dynamic Coronary Roadmap: does it really help reduce contrast use?

Dr. Juan Manuel Pérez - 0
Contrast-induced nephropathy remains a relevant complication of percutaneous coronary interventions (PCI), particularly in patients with multiple comorbidities and complex coronary anatomies. Dynamic Coronary Roadmap...

Endoleaks after endovascular repair of complex aortic aneurysms: always reintervene or monitor with CTA?

Dr. Juan Manuel Pérez - 0
Endovascular repair of thoracoabdominal aneurysms requiring sealing above the renal arteries, with preservation of visceral vessels using fenestrated and/or branched devices (F/B-EVAR), has become...

Is it safe to use negative chronotropic drugs early after TAVI?

Dr. Juan Manuel Pérez - 0
TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Institutional News

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy